Monica Reddy Muppidi, MD & Saby George, MD | Authors

Articles

Immune Checkpoint Inhibitors in Renal Cell Carcinoma

October 28, 2015

Unspecific immunotherapy with interleukin-2 (IL-2) and interferon-alpha was regarded as the first effective therapy in patients with RCC, leading to remarkable clinical benefit in attaining durable complete responses.